Surfactant treatment for respiratory distress syndrome: a review.
作者信息
Morley C J
出版信息
J R Soc Med. 1984 Sep;77(9):788-92. doi: 10.1177/014107688407700915.
Abstract
摘要
相似文献
1
Surfactant treatment for respiratory distress syndrome: a review.
J R Soc Med. 1984 Sep;77(9):788-92. doi: 10.1177/014107688407700915.
2
The surfactants.
Am J Perinatol. 2000;17(7):335-43. doi: 10.1055/s-2000-13445.
3
Exogenous surfactant in acute respiratory distress syndrome: more is better.
Eur Respir J. 2002 May;19(5):787-9. doi: 10.1183/09031936.02.00284902.
4
Surfactant replacement therapy. New levels of understanding.
Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):834-6. doi: 10.1164/ajrccm/148.4_Pt_1.834.
5
Surfactant. Evolving issues.
Clin Perinatol. 1998 Mar;25(1):17-32.
6
Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
Acta Paediatr. 2006 Sep;95(9):1036-48. doi: 10.1080/08035250600615168.
7
Steroids, surfactant and lung disease.
Thorax. 1996 Sep;51(9):880-1. doi: 10.1136/thx.51.9.880.
8
[A case of severe respiratory distress syndrome treated with a surfactant of porcine origin (curosurf)].
An Esp Pediatr. 1990 Aug;33(2):160-2.
9
Surfactant therapy. Clinical implications.
Acta Paediatr. 1996 Jun;85(6):641. doi: 10.1111/j.1651-2227.1996.tb14113.x.
10
Testing surfactant treatment responses: a comparison of two models.
Biol Neonate. 1997;71(3):181-9. doi: 10.1159/000244414.
本文引用的文献
1
MICROAEROSOL ADMINISTRATION OF SYNTHETIC BETA-GAMMA-DIPALMITOYL-L-ALPHA-LECITHIN IN THE RESPIRATORY DISTRESS SYNDOME: A PRELIMINARY REPORT.
Can Med Assoc J. 1964 Jan 11;90(2):55-7.
2
Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs.
Arch Dis Child. 1980 Oct;55(10):758-65. doi: 10.1136/adc.55.10.758.
3
Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.
J Pediatr. 1982 Jan;100(1):101-7. doi: 10.1016/s0022-3476(82)80247-3.
4
Premature lambs rescued from respiratory failure with natural surfactant: clinical and biophysical correlates.
Pediatr Res. 1982 Jun;16(6):424-9. doi: 10.1203/00006450-198206000-00005.
5
Human surfactant: a therapeutic trial in premature rabbits.
J Pediatr. 1982 Apr;100(4):619-22. doi: 10.1016/s0022-3476(82)80769-5.
6
Metabolism of exogenously administered natural surfactant in the newborn lamb.
Pediatr Res. 1982 Sep;16(9):711-5. doi: 10.1203/00006450-198209000-00002.
7
Surfactant substitution; experimental models and clinical applications.
Lung. 1980;158(2):57-68. doi: 10.1007/BF02713705.
8
Duration and characteristics of treatment of premature lambs with natural surfactant.
J Clin Invest. 1981 Feb;67(2):370-5. doi: 10.1172/JCI110044.
9
Lung surfactants. III. Correlations among activities in vitro, in situ and in vivo, and chemical composition.
Chem Pharm Bull (Tokyo). 1983 Nov;31(11):4110-5. doi: 10.1248/cpb.31.4110.
10
Lung surfactants. II. Effects of fatty acids, triacylglycerols and protein on the activity of lung surfactant.
Chem Pharm Bull (Tokyo). 1983 Nov;31(11):4100-9. doi: 10.1248/cpb.31.4100.
Zotero 插件